The risk of mortality among people with type 2 diabetes in Latin America: A systematic review and meta‐analysis of population‐based cohort studies

Rodrigo M. Carrillo‐Larco; Noël C. Barengo; Leonardo Albitres‐Flores; Antonio Bernabe‐Ortiz

doi:10.1002/dmrr.3139

journal article Mar 04, 2019

The risk of mortality among people with type 2 diabetes in Latin America: A systematic review and meta‐analysis of population‐based cohort studies

Rodrigo M. Carrillo‐Larco Noël C. Barengo Leonardo Albitres‐Flores Antonio Bernabe‐Ortiz

Diabetes/Metabolism Research and Reviews Vol. 35 No. 4 · Wiley

View at Publisher Save 10.1002/dmrr.3139

Abstract

SummaryType 2 diabetes mellitus (T2DM) is associated with a high mortality risk, although the magnitude of this association remains unknown in Latin America (LA). We aimed to assess the strength of the association between T2DM and all‐cause and cause‐specific mortality in population‐based cohort studies in LA.Systematic review and meta‐analysis: inclusion criteria were (1) men and women 18 years old and above with T2DM; (2) study outcomes all‐cause and/or cause‐specific mortality; and (3) using people without T2DM as comparison group. Five databases (Scopus, Medline, Embase, Global Health, and LILACS) were searched. Risk of bias was evaluated with the ROBINS‐I criteria. Initially, there were 979 identified studies, of which 17 were selected for qualitative synthesis; 14 were included in the meta‐analysis (N = 416 821). Self‐reported T2DM showed a pooled relative risk (RR) of 2.49 for all‐causes mortality (I‐squared [I2] = 85.7%, p < 0.001; 95% confidence interval [CI], 1.96‐3.15). T2DM based on a composite definition was associated with a 2.26‐fold higher all‐cause mortality (I2 = 93.9%, p < 0.001; 95% CI, 1.36‐3.74). The pooled risk estimates were similar between men and women, although higher at younger ages. The pooled RR for cardiovascular mortality was 2.76 (I2 = 59.2%; p < 0.061; 95% CI, 1.99‐3.82) and for renal mortality 15.85 (I2 = 0.00%; p < 0.645; 95% CI, 9.82‐25.57). Using available population‐based cohort studies, this work has identified and estimated the strength of the association between T2DM and mortality in LA. The higher mortality risk compared with high‐income countries deserves close attention from health policies makers and clinicians to improve diabetes care and control hence preventing complications and delaying death.

Topics

No keywords indexed for this article. Browse by subject →

References

59

[1]

International Diabetes Federation (IDF) (2017)

[2]

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

Gregory A Roth, Degu Abate, Kalkidan Hassen Abate et al.

The Lancet 10.1016/s0140-6736(18)32203-7

[3]

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Jeffrey D Stanaway, Ashkan Afshin, Emmanuela Gakidou et al.

The Lancet 10.1016/s0140-6736(18)32225-6

[4]

10.1016/s0140-6736(18)32335-3

[5]

10.1016/s0140-6736(18)32335-3

[6]

10.1016/j.ijcard.2013.07.224

[7]

Mortality Trends in Men and Women with Diabetes, 1971 to 2000

Edward W. Gregg, Qiuping Gu, Yiling J. Cheng et al.

Annals of Internal Medicine 10.7326/0003-4819-147-3-200708070-00167

[8]

10.2337/dc17-1962

[9]

Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants

Bin Zhou, James Bentham, Mariachiara Di Cesare et al.

The Lancet 10.1016/s0140-6736(16)31919-5

[10]

10.1016/s0140-6736(16)00618-8

[11]

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

The Lancet 10.1016/s0140-6736(16)30054-x

[12]

Health-system reform and universal health coverage in Latin America

Rifat Atun, Luiz Odorico Monteiro de Andrade, Gisele Almeida et al.

The Lancet 10.1016/s0140-6736(14)61646-9

[13]

10.1371/journal.pmed.1000100

[14]

10.1093/ije/dyx116

[15]

10.1038/s41598-018-23812-6

[16]

OuzzaniMA‐O HammadyH FedorowiczZ ElmagarmidA.Rayyan‐a web and mobile app for systematic reviews. (2046‐4053 (Electronic)).

[17]

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan AC Sterne, Miguel A Hernán, Barnaby C Reeves et al.

BMJ 10.1136/bmj.i4919

[18]

HigginsJPT GreenS eds.Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration;2011.www.handbook.cochrane.org.

[19]

10.1056/nejmoa1605368

[20]

10.1590/s1415-790x2003000300006

[21]

10.2337/db18-1671-p

[22]

10.2337/db18-1569-p

[23]

10.1177/0898264317708882

[24]

10.1046/j.1532-5415.2002.50016.x

[25]

10.2337/dc08-1948

[26]

10.1016/j.annepidem.2011.07.003

[27]

10.1371/journal.pone.0014588

[28]

10.1186/1471-2458-14-194

[29]

Llibre JJ "Frailty, dependency and mortality predictors in a cohort of Cuban older adults, 2003‐2011" MEDICC Rev (2014) 10.37757/mr2014.v16.n1.6

[30]

10.1093/gerona/glu165

[31]

10.1093/eurpub/ckv225

[32]

10.1002/jbmr.2795

[33]

10.1016/s2213-8587(18)30050-0

[34]

Lozano‐Esparza S "Abstract P073: diabetes and all cause and cause‐specific mortality in 111,300 Mexican women with healthcare coverage" Circulation (2018) 10.1161/circ.137.suppl_1.p073

[35]

10.1093/ije/17.1.62

[36]

10.1056/nejmoa1008862

[37]

10.1016/j.diabres.2018.01.038

[38]

10.1056/nejmoa1504347

[39]

10.1001/archinte.164.13.1422

[40]

10.1186/s12933-017-0583-x

[41]

10.2337/dc12-1513

[42]

10.2337/dc16-1616

[43]

10.1111/j.1464-5491.2010.03075.x

[44]

10.1155/2017/2042980

[45]

10.1371/journal.pone.0013582

[46]

10.1152/physrev.00053.2003

[47]

10.1186/s12872-018-0914-1

[48]

10.1900/rds.2014.11.138

[49]

10.2337/dc16-0155

[50]

10.1111/dme.13020

Showing 50 of 59 references

Cited By

46

Cardiovascular Disease Prognostic Models in Latin America and the Caribbean: A Systematic Review

Rodrigo M. Carrillo-Larco, Carlos Altez-Fernandez · 2019

Global Heart

Metrics

46

Citations

59

References

Details

Published: Mar 04, 2019
Vol/Issue: 35(4)
License: View

Authors

R

Rodrigo M. Carrillo‐Larco

Department of Epidemiology and Biostatistics, School of Public Health Imperial College London London UK; CRONICAS Centre of Excellence in Chronic Diseases Universidad Peruana Cayetano Heredia Lima Peru

N

Noël C. Barengo

Department of Medical and Population Health Sciences Research, Herbert Wertheim College of Medicine Florida International University Miami FL USA; Department of Public Health University of Helsinki Helsinki Finland

L

Leonardo Albitres‐Flores

CRONICAS Centre of Excellence in Chronic Diseases Universidad Peruana Cayetano Heredia Lima Peru; Facultad de Medicina Universidad Nacional de Trujillo Trujillo Peru; Sociedad Cientifica de Estudiantes de Medicina de la Universidad Nacional de Trujillo‐SOCEMUNT Trujillo Peru

A

Antonio Bernabe‐Ortiz

CRONICAS Centre of Excellence in Chronic Diseases Universidad Peruana Cayetano Heredia Lima Peru; Facultad de Ciencias de la Salud Universidad Peruana de Ciencias Aplicadas Lima Peru

Cite This Article

Rodrigo M. Carrillo‐Larco, Noël C. Barengo, Leonardo Albitres‐Flores, et al. (2019). The risk of mortality among people with type 2 diabetes in Latin America: A systematic review and meta‐analysis of population‐based cohort studies. Diabetes/Metabolism Research and Reviews, 35(4). https://doi.org/10.1002/dmrr.3139

The risk of mortality among people with type 2 diabetes in Latin America: A systematic review and meta‐analysis of population‐based cohort studies

You May Also Like